Glaxo Nears Deal on Human Genome
18:57 EDT 15 Jul 2012 | Wall Street Journal
GlaxoSmithKline is nearing an agreement to buy Human Genome Sciences for as much as $3 billion, dropping its months-long hostile pursuit of the U.S. biotechnology company.
Original Article: Glaxo Nears Deal on Human Genome
More From BioPortfolio on "Glaxo Nears Deal on Human Genome"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
